Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
en:aree:nmr:start [2018/07/18 19:07]
Gianluca Frustagli Traslated (to be revised).
en:aree:nmr:start [2023/02/16 01:50] (current)
Gianluca Frustagli
Line 1: Line 1:
-> FIXME **To be revised**\\ //(remove this paragraph once the translation is finished)// 
- 
 ~~NOTOC~~ ~~NOTOC~~
  
-**Area**+**NMR & MRI Area**
  
 <​html><​h2 style="​text-align:​ center;">​High resolution NMR and Preclinic MRI</​h2></​html>​ <​html><​h2 style="​text-align:​ center;">​High resolution NMR and Preclinic MRI</​h2></​html>​
  
-{{ :aree:nmr_mc:​banner-area.png?​900 |}}+\\ 
 + 
 +{{ :aree:nmr:​banner-area.png?​900 |}} 
 + 
 +\\ 
 + 
 +The NMR area is equipped with: 
 + 
 +  * a high resolution spectrometer operating at 14 T for metabolism and metabolomics studies in cells, biological fluids and tissues (high resolution NMR units);
  
-  * **[[:​en:​aree:​nmr_mc:​hrnmr:​start|The high-resolution Nuclear Magnetic Resonance (HR-NMR) Unit]]** is equipped with a spectrometer ​operating at 9.4 T for metabolism ​and metabolomics ​studies in cells, biological fluids and tissues. In particular, the HR-NMR Unit provides services for identification and detection of various classes of small molecules, metabolites,​ and lipids in mammalian and microbial cellstargeted and untargeted analyses and quantification of various classes of molecules ranging from small metabolites to lipids in a variety of biological matrices.+  * an MR system for in vivo imaging and spectroscopy for small animals ​operating at T for morphological,​ metabolic ​and functional imaging ​studies ​(in-vivo MRI unit);
  
-  * **[[:​en:​aree:​nmr_mc:​mri:​start|The preclinic MRI Unit]]** is equipped with a system for imagingoperating at 4.7 T for morphologicalmolecular ​and functional imaging and spectroscopy studies on rodents in vivo. Experience in neurodevelopmental and neurodegenerative pathology as well as several types of cancers in animal models to identify through quantitative protocols early biomarker of pathology progression or response to therapy.+The area makes use of pre-clinical research skills in oncologyneuroscienceaging and metabolic diseases.
  
 > Contact: [[rossella.canese@iss.it|Rossella Canese]] > Contact: [[rossella.canese@iss.it|Rossella Canese]]
 > ☎ **+39 06 4990 2567-3695** > ☎ **+39 06 4990 2567-3695**
  
 +/* > FIXME **To be revised.**\\ //(remove this paragraph once finished)// */